N-acetyltryptamine 1016-47-3 N-Acetyltryptamine;_x000D_ Tocris-0357;_x000D_ N-[2-(1H-indol-3-yl)ethyl]acetamide;_x000D_ N-(2-(1H-Indol-3-yl)ethyl)acetamide;_x000D_ Chicago Sky Blue 6B;

1-(4-chlorothiophen-2-yl)ethanone 34730-20-6 1-(4-Chlorothiophen-2-yl)ethanone;_x000D_ 1-(4-chlorothien-2-yl)ethanone;_x000D_ 4-chloro-2-acetylthiophene;_x000D_ ZLD0519;_x000D_ 1-(4-Chlor-2-thienyl)-ethanon;_x000D_ 1-(4-chloro-2-thienyl)ethanone;_x000D_ 2-acetyl-4-chlorothiophene;

[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[(2S)-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-2,3-dihydrochromen-7-yl]oxy]oxan-2-yl]methyl acetate 118985-26-5 Viscumneoside VI;

3-Bromo-5-fluoropicolinic acid 1189513-55-0 3-Bromo-5-fluoropyridine-2-carboxylic acid;

3-[(1S)-5-cyano-1-(4-fluorophenyl)-3H-2-benzofuran-1-yl]-N,N-dimethylpropan-1-amine oxide 917482-45-2 (S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile N1-Oxide;_x000D_ (S)-Citalopram N-Oxide;_x000D_ (S)-1-[3-(Dimethyloxidoamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile;

5-Bromo-4-hydroxynicotinic acid 1052114-83-6 5-bromo-4-oxo-1H-pyridine-3-carboxylic acid;

4-(icosa-5,8,11,14-tetraenoylamino)butanoic acid 128201-89-8 HMS3268I12;_x000D_ Rac1 Inhibitor F56,control peptide;

2-(3-aminophenyl)-N-(4-methylphenyl)sulfonylacetamide 402508-84-3 Benzeneacetamide,3-amino-N-[(4-methylphenyl)sulfonyl];_x000D_ N-[2-(3-aminophenyl)acetyl]-4-methylbenzenesulfonamide;

flavylium 11029-12-2 ANTHOCYANIN;_x000D_ InChI=1/C15H11O/c1-2-6-12(7-3-1)15-11-10-13-8-4-5-9-14(13)16-15/h1-11H/q+;_x000D_ Flavylium;_x000D_ 2-phenylchromenylium;

5-Methylthio-1,3,4-Thiadiazole-2-Thiol 6264-40-0 5-methylsulfanyl-3H-1,3,4-thiadiazole-2-thione;